Therapeutic alternatives for antihistamine-refractory urticaria;Therapeutische alternativen bei antihistamintherapie-refraktärer urtikaria

Hautarzt

Volumn 61, Issue 9, 2010, Pages 765-769

  Maurer, M ^a   Altrichter, S ^a   Ardelean, E ^a   Krause, K ^a   Magerl, M ^a   Metz, M ^a   Siebenhaar, F ^a   Weller, K ^a   Zuberbier, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allergy; Dermatology; Non sedating antihistamines; Therapy; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOSPORIN A; DAPSONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB;

CHRONIC URTICARIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; QUALITY OF LIFE; REVIEW; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DRUG COMBINATIONS; HISTAMINE ANTAGONISTS; HUMANS; TREATMENT FAILURE; URTICARIA;

EID: 77957809143     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-010-1934-7     Document Type: Review

References (23)

1. Bindslev-Jensen C, Skov PS (2009) Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 65:138-139
2. Boyce JA (2006) Successful treatment of cold-induced urticaria/ anaphylaxis with anti-IgE. J Allergy Clin Immunol 117:1415-1418
3. Cassano N, D Argento V, Filotico R, Vena GA (2005) Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol 85:254-255
4. Church MK, Maurer M, Simons FER et al (2010) Risk of first-generation H1-antihistamines: a GA2LEN position paper. Allergy (im Druck)
5. Di Gioaccino M, Di Stefano F, Cavallucci E et al (2003) Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 24:285-290
6. Engin B, Ozdemir M (2008) Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 22:481-486
7. Giménez-Arnau A, Izquierdo I, Maurer M (2009) The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 23:1088-1091
8. Grattan CEH, O'Donnell BF, Francis DM et al (2000) Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br J Dermatol 143:365-372
9. Grob JJ, Auquier P, Dreyfus I, Ortonne JP (2009) How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs. PRN and quality of life. Allergy 64:605-612
10. Güzelbey O, Ardelean E, Magerl M et al (2008) Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 63:1563-1565
11. Kaplan AP, Joseph K, Maykut RJ et al (2008) Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 122:569-573
12. Krause K, Ardelean E, Keßler B et al (2010) Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy (im Druck)
13. Magerl M, Staubach P, Maurer M (2010) Effective treatment of therapy resistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol (im Druck)
14. Metz M, Bergmann P, Zuberbier T, Maurer M (2008) Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 63:247-249
15. Metz M, Maurer M, Zuberbier T, Magerl M (2009) Diagnostik und Therapie der chronischen Urtikaria. Was ändert sich mit den neuen EAACI/GA2LEN/EDF/WAO Leitlinien für die Betreuung von Patienten mit Urtikaria? Dtsch Dermatologe 1111:1-6
16. Młynek A, Zalewska-Janowska A, Martus P et al (2008) How to assess disease activity in patients with chronic urticaria? Allergy 63:777-780
17. Siebenhaar F, Degener F, Zuberbier T et al (2009) High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 123:672-679
18. Spector SL, Tan RA (2007) Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 99:190-193
19. Spector SL, Tan RA (2008) Therapeutic alternatives for chronic urticaria: additional reports on omalizumab. Ann Allergy Asthma Immunol 101:647
20. Staevska M, Popov TA, Kralimarkova T et al (2010) The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 125:676-6826
21. Vena GA, Cassano N, Colombo D et al (2006) Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 55:705-709
22. 2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64:1417-1426
23. 2LEN/EDF/WAO guideline: management of urticaria. Allergy 64:1427-1443